Published in

Elsevier, Immunity, 6(33), p. 929-941, 2010

DOI: 10.1016/j.immuni.2010.11.024

Links

Tools

Export citation

Search in Google Scholar

An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness

Journal article published in 2010 by Claudio Procaccini, Veronica De Rosa ORCID, Mario Galgani ORCID, Luisa Abanni, Gaetano Cal{̀ı}, Gaetano Calì, Antonio Porcellini ORCID, Fortunata Carbone, Silvia Fontana, Tamas L. Horvath, Antonio La Cava, Giuseppe Matarese, Others
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

There is a discrepancy between the in vitro anergic state of CD4(+)CD25(hi)FoxP3(+) regulatory T (Treg) cells and their in vivo proliferative capability. The underlying mechanism of this paradox is unknown. Here we show that the anergic state of Treg cells depends on the elevated activity of the mammalian target of rapamycin (mTOR) pathway induced by leptin: a transient inhibition of mTOR with rapamycin, before T cell receptor (TCR) stimulation, made Treg cells highly proliferative in the absence of exogenous interleukin-2 (IL-2). This was a dynamic and oscillatory phenomenon characterized by an early downregulation of the leptin-mTOR pathway followed by an increase in mTOR activation necessary for Treg cell expansion to occur. These data suggest that energy metabolism, through the leptin-mTOR-axis, sets responsiveness of Treg cells that use this information to control immune tolerance and autoimmunity.